Capping Costs for Consumers Act of 2026

The 'Capping Costs for Consumers Act of 2026' (HR7164) was introduced in the House of Representatives on January 20, 2026, by Rep. Schrier (D-WA-8) and Ms. Budzinski. The bill has been referred to the Committee on Energy and Commerce, and the Committee on Ways and Means. This early stage indicates that the bill has begun its legislative journey but has significant steps remaining before potential passage. The bill aims to expand cost-sharing reductions for qualified health plans offered through an Exchange. Specifically, it amends Section 1402 of the Patient Protection and Affordable Care Act to apply cost-sharing reduction calculations as if the reference to the silver level of coverage were a reference to the gold level of coverage, effective for plan years beginning on or after January 1, 2028. This legislative change does not directly appropriate funds but rather modifies the formula for existing government subsidies, which would lead to increased government outlays for cost-sharing reductions. The mechanism is a re-calculation of existing subsidy structures, not a new funding authorization. Health insurers, such as UnitedHealth Group ($UNH), The Cigna Group ($CI), and Humana Inc. ($HUM), are positioned as structural beneficiaries if this bill passes. By reducing out-of-pocket costs for consumers, the legislation could lead to increased enrollment in qualified health plans and improved retention rates, thereby enhancing revenue stability for these companies. CVS Health Corporation ($CVS), which includes Aetna, would also benefit from increased enrollment and reduced churn within its health insurance segment. The bill's focus on consumer affordability could expand the market for health plans. Looking at recent market data, UnitedHealth Group ($UNH) is currently at $281.36, showing a 7-day change of +7.48% but a 30-day change of -2.57%. The Cigna Group ($CI) is at $275.69, with a 7-day change of +6.82% and a 30-day change of -1.98%. Humana Inc. ($HUM) is at $182.65, with a 7-day change of +10.03% and a 30-day change of +1.05%. CVS Health Corporation ($CVS) is at $73.28, with a 7-day change of +4.48% but a 30-day change of -6.88%. All four companies have seen positive movement over the last seven days, despite mixed performance over the last 30 days. The legislative path for HR7164 involves committee consideration, potential floor votes in the House and Senate, and ultimately presidential assent. Given its early stage, this process will take time, with the earliest effective date for the changes being January 1, 2028. Legislative steps remaining include committee hearings, markups, potential votes in both the House and Senate, and reconciliation if differences arise between versions passed by each chamber. The bill's effective date of January 1, 2028, provides a long lead time for health insurers to adapt to the potential changes, should the bill become law.